Fundraising Fox

Model Medicines

La Jolla, US · Founded 2019 · Delaware corporation · 2 known investors

modelmedicines.com ↗

Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms. The company has programs in infectious disease, oncology, and inflammation, with compounds in development including a broad-spectrum antiviral and a BRD4 inhibitor.

AI & Machine LearningBiotechDeep TechDigital Healthin /modelmedicines@modelmedicines

Founders & leadership

DHDaniel Haders
Daniel Hadersin𝕏Executive Officer, Director
KQ
Kip QuackenbushExecutive Officer, Director
ME
Marlon EvansExecutive Officer, Director

Investors · 2

8VCAustin · $500K – $50M
ParticleHong Kong · $1M – $6.9M

Reported raises · per SEC filings

Form D private placements
▶$3.3MraisedNov 2025 · 10 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HadersExecutive Officer
Offering amount
$5M
Amount sold
$3.3M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.8MraisedOct 2024 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kip QuackenbushExecutive Officer, Director
  • Daniel HadersExecutive Officer, Director
  • Marlon EvansExecutive Officer, Director
Amount sold
$14.8M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$950KraisedFeb 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HadersExecutive Officer, Director
  • Marlon EvansExecutive Officer, Director
  • Kip QuackenbushExecutive Officer, Director
Offering amount
$2M
Amount sold
$950K
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedNov 2021 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kip QuackenbushExecutive Officer, Director
  • Marlon EvansExecutive Officer, Director
  • Daniel HadersExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news